GB2362826A — A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
Assigned to Eli Lilly and Co · Expires 2001-12-05 · 24y expired
What this patent protects
A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin receptor, 5-HT<SB>1D</SB>, antagonist, together with a pharmaceutically acceptable diluent or carrier is claimed. Preferably the serotonin transport inhibitor is fluoxetine, duloxe…
USPTO Abstract
A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin receptor, 5-HT<SB>1D</SB>, antagonist, together with a pharmaceutically acceptable diluent or carrier is claimed. Preferably the serotonin transport inhibitor is fluoxetine, duloxetine, venlafaxine, milnacipran, citalpram, fluovoxamine, sertraline or nefazodone.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.